Single-dose Study to Describe the Safety of Sarilumab and Tocilizumab in Patients With Rheumatoid Arthritis

NCT02404558 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

DRUG: sarilumab SAR153191 (REGN88)
DRUG: tocilizumab

Sponsor

Sanofi

Collaborators

[object Object]